Schoonenboom NS - Search Results

1

Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.

Ewers M, Buerger K, Teipel SJ, Scheltens P, Schröder J, Zinkowski RP, Bouwman FH, Schönknecht P, Schoonenboom NS, Andreasen N, Wallin A, DeBernardis JF, Kerkman DJ, Heindl B, Blennow K, Hampel H. Ewers M, et al. Among authors: schoonenboom ns. Neurology. 2007 Dec 11;69(24):2205-12. doi: 10.1212/01.wnl.0000286944.22262.ff. Neurology. 2007. PMID: 18071141

2

Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients.

Galimberti D, Schoonenboom N, Scarpini E, Scheltens P; Dutch-Italian Alzheimer Research Group. Galimberti D, et al. Ann Neurol. 2003 Apr;53(4):547-8. doi: 10.1002/ana.10531. Ann Neurol. 2003. PMID: 12666129 No abstract available.

3

Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations.

Rosso SM, van Herpen E, Pijnenburg YA, Schoonenboom NS, Scheltens P, Heutink P, van Swieten JC. Rosso SM, et al. Among authors: schoonenboom ns. Arch Neurol. 2003 Sep;60(9):1209-13. doi: 10.1001/archneur.60.9.1209. Arch Neurol. 2003. PMID: 12975285

4

Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease.

Schoonenboom NS, Pijnenburg YA, Mulder C, Rosso SM, Van Elk EJ, Van Kamp GJ, Van Swieten JC, Scheltens P. Schoonenboom NS, et al. Neurology. 2004 May 11;62(9):1580-4. doi: 10.1212/01.wnl.0000123249.58898.e0. Neurology. 2004. PMID: 15136685

5

CSF tau and Abeta42 are not useful in the diagnosis of frontotemporal lobar degeneration.

Pijnenburg YA, Schoonenboom NS, Rosso SM, Mulder C, Van Kamp GJ, Van Swieten JC, Scheltens P. Pijnenburg YA, et al. Among authors: schoonenboom ns. Neurology. 2004 May 11;62(9):1649. doi: 10.1212/01.wnl.0000123014.03499.a7. Neurology. 2004. PMID: 15136709 No abstract available.

6

Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.

Schoonenboom NS, Mulder C, Vanderstichele H, Van Elk EJ, Kok A, Van Kamp GJ, Scheltens P, Blankenstein MA. Schoonenboom NS, et al. Clin Chem. 2005 Jan;51(1):189-95. doi: 10.1373/clinchem.2004.039735. Epub 2004 Nov 11. Clin Chem. 2005. PMID: 15539465

7

Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?

Schoonenboom NS, Mulder C, Van Kamp GJ, Mehta SP, Scheltens P, Blankenstein MA, Mehta PD. Schoonenboom NS, et al. Ann Neurol. 2005 Jul;58(1):139-42. doi: 10.1002/ana.20508. Ann Neurol. 2005. PMID: 15984010

8

Cerebrospinal fluid tau levels in frontotemporal dementia.

Verbeek MM, Pijnenburg YA, Schoonenboom NS, Kremer BP, Scheltens P. Verbeek MM, et al. Among authors: schoonenboom ns. Ann Neurol. 2005 Oct;58(4):656-7; author reply 657. doi: 10.1002/ana.20642. Ann Neurol. 2005. PMID: 16178027 No abstract available.

9

Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration.

Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Venturelli E, Pijnenburg YA, Bresolin N, Scarpini E. Galimberti D, et al. Neurology. 2006 Jan 10;66(1):146-7. doi: 10.1212/01.wnl.0000191324.08289.9d. Neurology. 2006. PMID: 16401871 No abstract available.

10

Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.

Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Bouwman F, Venturelli E, Guidi I, Blankenstein MA, Bresolin N, Scarpini E. Galimberti D, et al. Arch Neurol. 2006 Apr;63(4):538-43. doi: 10.1001/archneur.63.4.538. Arch Neurol. 2006. PMID: 16606766

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page